RIPE-KG · Version 1.1.0 · Resource
ripekg:author/RIPEAUFF859281894E1520
https://w3id.org/ripe/ripe-kg/author/RIPEAUFF859281894E1520
| Subject | Predicate | Object |
|---|---|---|
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
rdf:type |
node1 |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
rdf:type |
owl:Thing |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
rdf:type |
prov:Person |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
rdf:type |
foaf:Person |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
owl:sameAs |
https://semopenalex.org/author/A5087444879 |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
foaf:familyName |
Afshar Ebrahimi |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
foaf:givenName |
Faraneh |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
foaf:name |
Faraneh Afshar Ebrahimi |
ripekg:retraction-notice/28449The Effects of Magnesium and Zinc Co-Supplementation on Biomarkers of Inflammation and Oxidative Stress, and Gene Expression Related to Inflammation in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Trial |
ripe:concerns |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
ripekg:retraction-notice/28465Effects of Selenium Supplementation on Gene Expression Levels of Inflammatory Cytokines and Vascular Endothelial Growth Factor in Patients with Gestational Diabetes |
ripe:concerns |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
ripekg:retraction-notice/43982Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
ripekg:retraction-notice/43984Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial |
ripe:concerns |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
ripekg:retraction-notice/67438Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
ripekg:work/10.1016%2Fj.jad.2017.12.049The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome |
dcterms:creator |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |